Swiss Health Angels

Evismo AG, founded in 2018 and headquartered in Zurich, Switzerland, specializes in web-based remote vital signs monitoring services, particularly focusing on cardiac health. The company offers CardioFlex, an advanced online ECG service that aids healthcare professionals, including general practitioners, cardiologists, clinics, and hospitals, in diagnosing and managing conditions such as cardiac arrhythmias, sleep apnea, and stress. By providing accessible ECG data, Evismo integrates patient-centered medical care into daily life, enabling timely diagnoses and enhancing treatment options. The company's approach emphasizes cost-effective solutions that improve overall patient outcomes in diagnostics, prevention, and therapy.

Abselion specializes in the development of biological sensors aimed at the rapid and cost-effective detection of various biological substances, including proteins, DNA, and small molecules. The company's innovative diagnostic analyzers and kits simplify the analysis of these biomolecules, making them valuable tools for pharmaceutical research and manufacturing. By enabling researchers to conduct sensitive, rapid, and near real-time medical diagnoses, Abselion enhances the understanding of biomolecular interactions, particularly in protein interaction analysis. This focus on efficiency and accuracy positions Abselion as a key player in the field of biosensing technology.